Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients

NCT05523739 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Infection

Interventions

DRUG: STI-1558

Sponsor

Zhejiang ACEA Pharmaceutical Co. Ltd.